Venture capitalists tempted by German medtech market
This article was originally published in Clinica
"Venture capitalists and other private investment companies are more ready than ever to invest in the German medical technology market," says Thom Rasche, director of the medical consultancy firm MEDEXPERT in Hamburg.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.